Who makes caplacizumab? The manufacturer behind Cablivi
•
4 min read
Cablivi (caplacizumab), a significant advancement in treating a rare blood-clotting disorder, was developed from a unique discovery in camel blood, leading to the creation of its innovative "nanobody" technology. Today, the global pharmaceutical company Sanofi is responsible for the manufacture and commercialization of caplacizumab.
